Roth Mkm Cuts MGP Ingredients (NASDAQ:MGPI) Price Target to $60.00

MGP Ingredients (NASDAQ:MGPI – Get Free Report) had its target price decreased by Roth Mkm from $65.00 to $60.00 in a research note issued to investors on Monday,Benzinga reports. The firm currently has a “buy” rating on the stock. Roth Mkm’s price target suggests a potential upside of 53.06% from the stock’s previous close. MGPI […]

Leave a Reply

Your email address will not be published.

Previous post Helius Medical Technologies, Inc. Announces First PoNS System Sale to VA Healthcare SystemOn December 23, 2024, Helius Medical Technologies, Inc. (NASDAQ:HSDT) disclosed its successful sale of the first Portable Neuromodulation Stimulator (PoNS) Syst
Next post Insider Selling: Harvey Norman Holdings Limited (ASX:HVN) Insider Sells 2,514 Shares of Stock